Aaron Sato
Chief Tech/Sci/R&D Officer bij TWIST BIOSCIENCE CORPORATION
Profiel
Momenteel is Aaron K. Sato Chief Scientific Officer bij Twist Bioscience Corp. In zijn vorige loopbaan was hij Vice President-Research bij Sutro Biopharma, Inc., Chief Scientific Officer van LakePharma, Inc., Vice President-Protein Sciences bij Surrozen, Inc., Director-Antibody Engineering bij OncoMed Pharmaceuticals, Inc. en Senior Director-Discovery bij Dyax Corp. Aaron K. Sato behaalde een doctoraat aan het Massachusetts Institute of Technology en een bachelorgraad aan de University of Puget Sound.
Actieve functies van Aaron Sato
| Bedrijven | Functie | Begin |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Aaron Sato
| Bedrijven | Functie | Einde |
|---|---|---|
LakePharma, Inc.
 LakePharma, Inc. Pharmaceuticals: MajorHealth Technology LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA. | Chief Tech/Sci/R&D Officer | 01-06-2018 |
| SUTRO BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 01-01-2017 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-01-2017 |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | 01-07-2012 |
| DYAX CORP. | Corporate Officer/Principal | 01-07-2006 |
Opleiding van Aaron Sato
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Puget Sound | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| TWIST BIOSCIENCE CORPORATION | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
LakePharma, Inc.
LakePharma, Inc. Pharmaceuticals: MajorHealth Technology LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA. | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Health Technology |
